62 Chapter 3 19. Mazure CM, Halmi KA, Sunday SR, Romano SJ, Einhorn AM. The Yale-Brown-Cornell eating disorder scale: development, use, reliability and validity. Journal of psychiatric research. 1994;28(5):425-45. 20. Engel SG, Wittrock DA, Crosby RD, Wonderlich SA, Mitchell JE, Kolotkin RL. Development and psychometric validation of an eating disorder-specific health-related quality of life instrument. International Journal of Eating Disorders. 2006;39(1):62-71. 21. Van Strien T. Eating Disorder Inventory II. Nederlandse versie (EDI-II NL). Lisse (Hallond): Swets & Zeitlinger Van Strien, T, & Ouwens, M(2003) Validation of the Dutch EDI-2 in one clinical and two nonclinical populations European Journal of Psychological Assessment. 2002;19(1):66-84. 22. Goossens L, Van Durme K. Assessment van eetstoornissymptomen: de Eating Disorder Examination. Psychopraktijk. 2011;3(5):26-30. 23. Krabbe PF, Stouthard ME, Essink-Bot ML, Bonsel GJ. The effect of adding a cognitive dimension to the EuroQol multiattribute health-status classification system. J Clin Epidemiol. 1999;52(4):293-301. 24. Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychological medicine. 1998;28(3):5518. 25. Ware Jr JE, Sherbourne CD. The MOS 36-item short-form health survey (SF36): I. Conceptual framework and item selection. Medical care. 1992:473-83. 26. Sheehan DV, Harnett-Sheehan K, Raj B. The measurement of disability. International clinical psychopharmacology. 1996. 27. Endicott J, Nee J, Harrison W, Blumenthal R. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacology bulletin. 1993. 28. Lesieur HR, Blume SB. The South Oaks Gambling Screen (SOGS): A new instrument for the identification of pathological gamblers. American journal of Psychiatry. 1987;144(9). 29. Arrindell W, Ettema J. SCL-90. Manual for a multidimensional indicator of psychopathology Lisse: Swets and Zeitlingen. 1986. 30. Goodman W, Rasmussen S, Price L, Mazure C, Heninger G, Charney D. Yale-brown obsessive compulsive scale (Y-BOCS). Verhaltenstherapie. 1991;1(3):226-33. 31. Fagerström K. Determinants of tobacco use and renaming the FTND to the Fagerström Test for Cigarette Dependence. Nicotine & Tobacco Research. 2011;14(1):75-8. 32. Ben-Tovim DI, Walker MK. The development of the Ben-Tovim Walker Body Attitudes Questionnaire (BAQ), a new measure of women’s attitudes towards their own bodies. Psychological medicine. 1991;21(3):775-84. 33. Rosenberg M. Rosenberg selfesteem scale (RSE). Acceptance and commitment therapy Measures package. 1965;61(52):18. 34. Hamilton M. A rating scale for depression. Journal of neurology, neurosurgery, and psychiatry. 1960;23(1):56. 35. Hamilton M. Hamilton anxiety scale. Group. 1959;1:4. 36. Shamim T, Golden NH, Arden M, Filiberto L, Shenker IR. Resolution of vital sign instability: an objective measure of medical stability in anorexia nervosa. J Adolesc Health. 2003;32(1):73-7. 37. Golden NH, Meyer W. Nutritional rehabilitation of anorexia nervosa. Goals and dangers. Int J Adolesc Med Health. 2004;16(2):131-44. 38. Hudson JI, Hiripi E, Pope Jr HG, Kessler RC. The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biological psychiatry. 2007;61(3):348-58. 39. Grassi G, Figee M, Ooms P, Righi L, Nakamae T, Pallanti S, et al. Impulsivity and decision-making in obsessivecompulsive disorder after effective deep brain stimulation or treatment as usual. CNS Spectr. 2018;23(5):333-9. 40. Figee M, Luigjes J, Smolders R, ValenciaAlfonso CE, van Wingen G, de Kwaasteniet B, et al. Deep brain stimulation restores frontostriatal network activity in obsessive-compulsive disorder. Nat Neurosci. 2013;16(4):386-7.
RkJQdWJsaXNoZXIy MjY0ODMw